3rd Annual Biosimilars Summit

This 3rd Annual Summit brings together industry experts to explore strategies and gain insight into designing new biosimilar development programmes and analysis methods, clinical advancement, and new solutions for successful implementation in the market.

It is a great environment for interactive networking, learning best practice, maintaining business relationships, and meeting new clients.


Key Practical Learning Points of the Summit:

  • The global regulatory landscape for biosimilars’ approval
  • The latest achievements of biosimilars in therapeutic areas
  • Bioanalytics for biosimilars
  • Extrapolation and Interchangeability
  • Immunogenicity
  • Pharmacovigilance issues
  • Developments in the biosimilar guideline framework
  • Drug safety factors
  • Legal considerations for biosimilars 
  • Successful implementation of biosimilars in the market

Who Should Attend:

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders and Managers specialising in:

  • Biologics/Biotechnology/ Biogenerics
  • Biopharmaceuticals
  • Legal Affairs
  • Intellectual property
  • Pricing and Reimbursement
  • Clinical Immunology
  • Regulatory Compliance
  • R&D
  • Preclinical and Clinical Development
  • New Product Development
  • Quality Affairs/ Quality Control
  • Pharmacovigilance

From Industries Including:

  • Clinical Immunology
  • Oncology
  • Immunology
  • Infection and Immunity
  • Drug Safety
  • Risk Management
  • Preclinical Development
  • Clinical Program
  • Therapeutic Areas
  • Personalized Medicine
  • Business Development
  • Portfolio Planning
  • Vaccines Development
  • Regulatory Affairs
  • Scientific Affairs
  • Pharmacovigilance
  • Validation
  • Global Strategy
  • Analytical Characterization
  • Antibody Engineering
  • Antibody Discovery
Media partners